These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 785411)

  • 1. Improvement of "irreversible" airway obstruction by thiazinamium (Multergan).
    Bouhuys A; Ortega J
    Pneumonologie; 1976 Jun; 153(3):185-95. PubMed ID: 785411
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostic and therapeutic use of thiazinamium (Multergan)].
    van Bork LE; Jonkman JH; de Zeeuw RA; Orie NG; Peset R; de Vries K
    Ned Tijdschr Geneeskd; 1977 Jul; 121(30):1196-202. PubMed ID: 887179
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigation into isoprenaline resistance in patients with obstructive lung disease.
    Lichterfeld A; Löllgen H
    Eur J Clin Pharmacol; 1974 Aug; 7(5):347-51. PubMed ID: 4609138
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical study on carbuterol (SKF 40383), a new selective bronchodilator agent aerosol: double blind comparison with isoproterenol aerosol.
    Saleeby PR; Ziskind MM
    Curr Ther Res Clin Exp; 1975 Mar; 17(3):225-33. PubMed ID: 805017
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism and excretion of the quaternary ammonium compound thiazinamium methylsulfate (Multergan) in man. I. Parenteral administration.
    Jonkman JH; Wijsbeek J; De Zeeuw RA; Van Bork LE; Orie NG; Soeterboek AM; Bender J
    Pharm Weekbl Sci; 1982 Oct; 4(5):122-8. PubMed ID: 6128713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings: Bioavailability of the quaternary ammonium compound thiazinamium methylsulphate (Multergan) after oral and intramuscular administration.
    Jonkman JH; Wijsbeek U; Brouwer SH; De Zeeuw RA
    J Pharm Pharmacol; 1974 Dec; 26 Suppl():63P. PubMed ID: 4156742
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative study of the effects of isoetharine and some other adrenergic beta-stimulators in chronic obstructive lung disease.
    Thiringer G; Bergh NP; Svedmyr N
    Scand J Respir Dis; 1971; 52(4):183-91. PubMed ID: 5161421
    [No Abstract]   [Full Text] [Related]  

  • 8. Method of using pressurized aerosols.
    Connolly CK
    Br Med J; 1975 Jul; 3(5974):21. PubMed ID: 1131657
    [No Abstract]   [Full Text] [Related]  

  • 9. Bronchodilatation by metered inhaler (Prenomiser) in obstructive airway disease.
    Store SD; Kamat SR; Purohit SD; Rane MA
    J Assoc Physicians India; 1974 Jul; 22(7):515-9. PubMed ID: 4436242
    [No Abstract]   [Full Text] [Related]  

  • 10. Variations in the bioavailability of thiazinamium methylsulfate.
    Jonkman JH; Van Bork LE; Wijsbeek J; De Zeeuw RK; Orie NG
    Clin Pharmacol Ther; 1977 Apr; 21(4):457-63. PubMed ID: 849677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term evaluation of a new aerosol bronchodilator, carbuterol, and comparison with isoproterenol.
    Drachler DH; Bower JS; Miller DA; Rotman HH
    J Clin Pharmacol; 1977; 17(11-12):734-9. PubMed ID: 336653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary resistance and maximal expiratory flowrate following isoprenaline in patients with chronic obstructive lung disease.
    Stănescu DC; Clément J; Van de Woestijne KP
    Thorax; 1973 Nov; 28(6):716-20. PubMed ID: 4787983
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of inhalation therapy on ventilatory function and expectoration.
    Shim C; Bajwa S; Williams MH
    Chest; 1978 Jun; 73(6):798-801. PubMed ID: 350510
    [No Abstract]   [Full Text] [Related]  

  • 14. Symposium on isoproterenol therapy in asthma.
    Ann Allergy; 1973 Jan; 31(1):1-44. PubMed ID: 4404961
    [No Abstract]   [Full Text] [Related]  

  • 15. A three month study of the bronchodilator effects of aerosolized fenoterol and isoproterenol.
    Beall GN; Steen SN; Kuo J; Smith R
    Chest; 1978 Jun; 73(6 Suppl):996-7. PubMed ID: 354893
    [No Abstract]   [Full Text] [Related]  

  • 16. Spirometry following glucagon and isoproterenol in chronic obstructive lung disease.
    el-Naggar M; Collins VJ
    Crit Care Med; 1974; 2(2):82-5. PubMed ID: 4832285
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of pressure-packed bornchodilator aerosols in chronic obstructive bronchitis.
    Chatterjee SS; Dinda P; Riding WD
    Scand J Respir Dis; 1971; 52(2):71-6. PubMed ID: 5170643
    [No Abstract]   [Full Text] [Related]  

  • 18. Aerosolized detergents and mucolytic agents in the treatment of stable chronic obstructive pulmonary disease.
    Barton AD
    Am Rev Respir Dis; 1974 Dec; 110(6 Pt 2):104-10. PubMed ID: 4613216
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of ventilation changes in patients with obstructive bronchopneumopathy induced by bronchodilator drugs].
    De Benedetto F; Cervone M; De Blasio E; D'Ilario F; Fuciarelli R; Luciano A; Sborgia M
    Clin Ter; 1984 Jun; 109(6):509-17. PubMed ID: 6236941
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of thiazinamium in asthmatic patients.
    Holford NH; Clements P; Collier P; Orie NG; van Bork LE; Jonkman JH
    Eur J Clin Pharmacol; 1987; 33(3):237-42. PubMed ID: 2891535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.